Agency Information Collection Activities; Submission for OMB Review; Proposed Collection; Comment Request for a Modified OGE Form 201 Ethics in Government Act Access Form, 24749-24750 [2013-09932]
Download as PDF
Federal Register / Vol. 78, No. 81 / Friday, April 26, 2013 / Notices
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than May 23, 2013.
A. Federal Reserve Bank of Richmond
(Adam M. Drimer, Assistant Vice
President) 701 East Byrd Street,
Richmond, Virginia 23261–4528:
1. CapGen Capital Group III LLC and
CapGen Capital Group III LP, both
located in New York, New York, to
increase their voting shares up to 25
percent of Seacoast Banking Corporation
of Florida, Stuart, Florida, and thereby
indirectly control Seacoast National
Bank, Stuart, Florida.
Board of Governors of the Federal Reserve
System, April 22, 2013.
Margaret McCloskey Shanks,
Deputy Secretary of the Board.
[FR Doc. 2013–09829 Filed 4–25–13; 8:45 am]
BILLING CODE 6210–01–P
GOVERNMENT ACCOUNTABILITY
OFFICE
Government Accountability
Office (GAO).
ACTION: Notice on letters of nomination.
AGENCY:
The American Recovery and
Reinvestment Act of 2009 (ARRA)
established the Health Information
Technology Policy Committee to make
recommendations on the
implementation of a nationwide health
information technology infrastructure to
the National Coordinator for Health
Information Technology. There is an
opening on the committee for a member
from the research community.
Candidates considered for this
appointment will be required to
complete a financial disclosure form.
For this appointment I am announcing
the following: Letters of nomination and
resumes should be submitted through
May 18, 2013 to ensure adequate
opportunity for review and
consideration of nominees.
ADDRESSES:
GAO: HITCommittee@gao.gov.
GAO: 441 G Street NW., Washington,
DC 20548.
FOR FURTHER INFORMATION CONTACT:
GAO: Office of Public Affairs, (202)
512–4800.
42 U.S.C. 300jj–2.
erowe on DSK2VPTVN1PROD with NOTICES
Gene L. Dodaro,
Comptroller General of the United States.
[FR Doc. 2013–09743 Filed 4–25–13; 8:45 am]
BILLING CODE 1610–02–M
VerDate Mar<15>2010
17:39 Apr 25, 2013
Jkt 229001
Agency Information Collection
Activities; Submission for OMB
Review; Proposed Collection;
Comment Request for a Modified OGE
Form 201 Ethics in Government Act
Access Form
AGENCY:
Office of Government Ethics
(OGE).
Notice of request for agency and
public comments.
ACTION:
After this first round notice
and public comment period, OGE plans
to submit a proposed modified OGE
Form 201 Ethics in Government Act
access form to the Office of Management
and Budget (OMB) for review and
approval of a three-year extension under
the Paperwork Reduction Act of 1995
(44 U.S.C. chapter 35). The OGE Form
201 is used by persons requesting access
to executive branch public financial
disclosure reports and other covered
records.
SUMMARY:
Written comments by the public
and the agencies on this proposed
extension are invited and must be
received by June 25, 2013.
ADDRESSES: Comments may be
submitted to OGE, by any of the
following methods:
Email: usoge@oge.gov. (Include
reference to ‘‘OGE Form 201 Paperwork
Comment’’ in the subject line of the
message.)
FAX: 202–482–9237, Attn: Paul D.
Ledvina.
Mail, Hand Delivery/Courier: U.S.
Office of Government Ethics, Suite 500,
1201 New York Avenue NW.,
Washington, DC 20005–3917, Attention:
Paul D. Ledvina, Agency Clearance
Officer.
DATES:
Health Information Technology Policy
Committee Appointment
SUMMARY:
OFFICE OF GOVERNMENT ETHICS
Mr.
Ledvina at the U.S. Office of
Government Ethics; telephone: 202–
482–9247; TTY: 800–877–8339; FAX:
202–482–9237; Email:
paul.ledvina@oge.gov. An electronic
copy of the OGE Form 201 version used
to manually submit access requests to
OGE or other executive branch agencies
by mail or FAX is available in the Forms
Library section of OGE’s Web site at
https://www.oge.gov. A paper copy may
also be obtained, without charge, by
contacting Mr. Ledvina. An automated
version of the OGE Form 201, also
available on OGE’s Web site, enables the
requester to fill out, submit and receive
immediate access to financial reports
and certain related records for
individuals who have been nominated
by the President to executive branch
positions requiring Senate confirmation,
FOR FURTHER INFORMATION CONTACT:
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
24749
and individuals who have declared their
candidacy for the Office of the President
of the United States.
SUPPLEMENTARY INFORMATION:
Title: Request to Inspect or Receive
Copies of Executive Branch Personnel
Public Financial Disclosure Reports or
Other Covered Records.
Agency Form Number: OGE Form
201.
OMB Control Number: 3209–0002.
Type of Information Collection:
Extension with modifications of a
currently approved collection.
Type of Review Request: Regular.
Respondents: Individuals requesting
access to executive branch public
financial disclosure reports and other
covered records.
Estimated Annual Number of
Respondents: 870.
Estimated Time per Response: 10
minutes.
Estimated Total Annual Burden: 145
hours.
Abstract: The OGE Form 201 collects
information from, and provides certain
information to, persons who seek access
to OGE Form 278/SF 278 Public
Financial Disclosure Reports, including
OGE Form 278–T Periodic Transaction
Reports, and other covered records. The
form reflects the requirements of the
Ethics in Government Act, subsequent
amendments pursuant to the STOCK
Act and OGE’s implementing
regulations that must be met by a person
before access can be granted. These
requirements relate to information
collected about the identity of the
requester, as well as any other person on
whose behalf a record is sought, and
notification of prohibited uses of
executive branch public disclosure
financial reports. See sections 105(b)
and (c) and 402(b)(1) of the Ethics in
Government Act, 5 U.S.C. appendix
§§ 105(b) and (c) and 402(b)(1), and 5
CFR 2634.603 (c) and (f) of OGE’s
executive branchwide regulations.
Executive branch departments and
agencies are encouraged to utilize the
OGE Form 201 for individuals seeking
access to public financial disclosure
reports and other covered documents.
OGE permits departments and agencies
to use or develop their own forms as
long as the forms collect and provide all
of the required information. OGE is
proposing several modifications to both
the non-automated and automated
versions of the OGE Form 201. OGE
proposes to modify the title of the form
and add a warning to requestors that
intentional falsification of the
information required by the form may
result in prosecution under 18 U.S.C.
§ 1001. OGE is proposing that this
E:\FR\FM\26APN1.SGM
26APN1
24750
Federal Register / Vol. 78, No. 81 / Friday, April 26, 2013 / Notices
renewal request to OMB also cover the
fully automated version of the OGE
Form 201, available only through the
OGE Web site at www.oge.gov. Initially
launched in March 2012, this automated
version of the access form enables a
requestor to obtain immediately upon
Web site submission of the completed
form, those financial disclosure reports
of individuals who have been
nominated by the President to executive
branch positions requiring Senate
confirmation. In addition, OGE reviews
the public financial disclosure report of
individuals who have declared their
candidacy for the Office of the President
of the United States. Those certified
reports may also be requested by
submitting a completed automated OGE
Form 201.
Request for Comments: OGE is
publishing this first round notice of its
intent to request paperwork clearance
for a proposed modified OGE Form 201
Ethics Act Access Form. Agency and
public comment is invited specifically
on the need for and practical utility of
this information collection, the accuracy
of OGE’s burden estimate, the
enhancement of quality, utility and
clarity of the information collected, and
the minimization of burden (including
the use of information technology).
Comments received in response to this
notice will be summarized for, and may
be included with, the OGE request for
extension of OMB paperwork approval.
The comments will also become a
matter of public record.
Approved: April 22, 2013.
Walter M. Shaub, Jr.,
Director, U.S. Office of Government Ethics.
[FR Doc. 2013–09932 Filed 4–25–13; 8:45 am]
BILLING CODE 6345–03–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Scientific Information Request
Therapies for Clinically Localized
Prostate Cancer
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Request for Scientific
Information Submissions.
AGENCY:
The Agency for Healthcare
Research and Quality (AHRQ) is seeking
scientific information submissions from
medical device manufacturers with
products falling within the following
UMDNS product codes: Brachytherapy
Systems [20–352]; Cyclotrons [15–818];
Radiotherapy Systems, Linear
erowe on DSK2VPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
17:39 Apr 25, 2013
Jkt 229001
Accelerator [12–364]; Radiotherapy
Systems, and Proton Beam [20–546].
Scientific information is being solicited
to inform the update of our Comparative
Effectiveness Review of Therapies for
Clinically Localized Prostate Cancer
which is currently being conducted by
one of the Evidence-based Practice
Centers for the AHRQ Effective Health
Care Program. Access to published and
unpublished pertinent scientific
information on this device will improve
the quality of this comparative
effectiveness review. AHRQ is
requesting this scientific information
and conducting this comparative
effectiveness review pursuant to Section
1013 of the Medicare Prescription Drug,
Improvement, and Modernization Act of
2003, Public Law 108–173.
DATES: Submission-Deadline-on orbefore May 28, 2013.
ADDRESSES:
Email submissions: sips@epc-src.org.
Print submissions:
Mailing Address: Portland VA
Research Foundation, Scientific
Resource Center, ATTN: Scientific
Information Packet Coordinator, PO Box
69539, Portland, OR 97239.
Shipping Address: (FedEx, UPS,
etc) Portland VA Research Foundation,
Scientific Resource Center, ATTN:
Scientific Information Packet
Coordinator, 3710 SW US Veterans
Hospital Road, Mail Code: R&D 71,
Portland, OR 97239.
FOR FURTHER INFORMATION CONTACT:
Robin Paynter, Scientific Information
Packet Coordinator, Telephone: 503–
220–8262 x58652 or Email: sips@epcsrc.org.
SUPPLEMENTARY INFORMATION: In
accordance with Section 1013 of the
Medicare Prescription Drug,
Improvement, and Modernization Act of
2003, Public Law 108–173, the Agency
for Healthcare Research and Quality has
commissioned one of the Effective
Health Care (EHC) Program Evidencebased Practice Centers to complete a
comparative effectiveness review of the
evidence for Therapies for Clinically
Localized Prostate Cancer: An Update of
a 2008 Comparative Effectiveness
Review.
The EHC Program is dedicated to
identifying as many studies as possible
that are relevant to the questions for
each of its reviews. In order to do so, we
are supplementing the usual manual
and electronic database searches of the
literature by requesting information
(e.g., details of studies conducted)
through public information requests,
including via the Federal Register and
direct postal and/or online solicitations.
We are looking for studies that report on
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
Therapies for Clinically Localized
Prostate Cancer, including those that
describe adverse events, as specified in
the key questions detailed below. The
entire research protocol, including the
key questions, is also available online
at: https://www.effectivehealthcare.
AHRQ.gov/search-for-guides-reviewsand-reports/?pageaction=display
product&productID=1434#7270.
This notice is a request for
information about the following:
• A current product label, if
applicable (preferably an electronic PDF
file).
• Information identifying published
randomized controlled trials and
observational studies relevant to the
clinical outcomes. AHRQ is interested
in receiving both citations and reprints.
Information identifying unpublished
randomized controlled trials and
observational studies relevant to the
clinical outcomes. If possible, please
provide a summary that includes the
following elements: study number,
study period, design, methodology,
indication and diagnosis, proper use
instructions, inclusion and exclusion
criteria, primary and secondary
outcomes, baseline characteristics,
number of patients. screened/eligible/
enrolled/lost to withdrawn/follow-up/
analyzed, and effectiveness/efficacy and
safety results.
• Registered ClinicalTrials.gov
studies. Please provide a list including
the ClinicalTrials.gov identifier,
condition, and intervention.
Your contribution is very beneficial to
this-program. This is a-voluntaryrequest for information, and all costs for
complying with this request must be
borne by the submitter. You may wish
to indicate whether or not the
submission comprises all of the
complete information available.
Please Note: The contents of all
submissions, regardless of format, will
be available to the public upon request
unless prohibited by law.
The draft of this review will be posted
on AHRQ’s EHC program Web site and
available for public comment for a
period of 4 weeks. If you would like to
be notified when the draft is posted,
please sign up for the email list at:
https://effectivehealthcare.AHRQ.gov/
index.cfm/join-the-email-list1/.
Scope and Key Questions
This update examines the same four
key questions as in the original 2008
report on the comparative effectiveness
of treatments for clinically localized
prostate cancer. Although these key
questions were reviewed and approved
by AHRQ and discussed with Technical
Expert Panel (TEP) members for the
E:\FR\FM\26APN1.SGM
26APN1
Agencies
[Federal Register Volume 78, Number 81 (Friday, April 26, 2013)]
[Notices]
[Pages 24749-24750]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-09932]
-----------------------------------------------------------------------
OFFICE OF GOVERNMENT ETHICS
Agency Information Collection Activities; Submission for OMB
Review; Proposed Collection; Comment Request for a Modified OGE Form
201 Ethics in Government Act Access Form
AGENCY: Office of Government Ethics (OGE).
ACTION: Notice of request for agency and public comments.
-----------------------------------------------------------------------
SUMMARY: After this first round notice and public comment period, OGE
plans to submit a proposed modified OGE Form 201 Ethics in Government
Act access form to the Office of Management and Budget (OMB) for review
and approval of a three-year extension under the Paperwork Reduction
Act of 1995 (44 U.S.C. chapter 35). The OGE Form 201 is used by persons
requesting access to executive branch public financial disclosure
reports and other covered records.
DATES: Written comments by the public and the agencies on this proposed
extension are invited and must be received by June 25, 2013.
ADDRESSES: Comments may be submitted to OGE, by any of the following
methods:
Email: usoge@oge.gov. (Include reference to ``OGE Form 201
Paperwork Comment'' in the subject line of the message.)
FAX: 202-482-9237, Attn: Paul D. Ledvina.
Mail, Hand Delivery/Courier: U.S. Office of Government Ethics,
Suite 500, 1201 New York Avenue NW., Washington, DC 20005-3917,
Attention: Paul D. Ledvina, Agency Clearance Officer.
FOR FURTHER INFORMATION CONTACT: Mr. Ledvina at the U.S. Office of
Government Ethics; telephone: 202-482-9247; TTY: 800-877-8339; FAX:
202-482-9237; Email: paul.ledvina@oge.gov. An electronic copy of the
OGE Form 201 version used to manually submit access requests to OGE or
other executive branch agencies by mail or FAX is available in the
Forms Library section of OGE's Web site at https://www.oge.gov. A paper
copy may also be obtained, without charge, by contacting Mr. Ledvina.
An automated version of the OGE Form 201, also available on OGE's Web
site, enables the requester to fill out, submit and receive immediate
access to financial reports and certain related records for individuals
who have been nominated by the President to executive branch positions
requiring Senate confirmation, and individuals who have declared their
candidacy for the Office of the President of the United States.
SUPPLEMENTARY INFORMATION:
Title: Request to Inspect or Receive Copies of Executive Branch
Personnel Public Financial Disclosure Reports or Other Covered Records.
Agency Form Number: OGE Form 201.
OMB Control Number: 3209-0002.
Type of Information Collection: Extension with modifications of a
currently approved collection.
Type of Review Request: Regular.
Respondents: Individuals requesting access to executive branch
public financial disclosure reports and other covered records.
Estimated Annual Number of Respondents: 870.
Estimated Time per Response: 10 minutes.
Estimated Total Annual Burden: 145 hours.
Abstract: The OGE Form 201 collects information from, and provides
certain information to, persons who seek access to OGE Form 278/SF 278
Public Financial Disclosure Reports, including OGE Form 278-T Periodic
Transaction Reports, and other covered records. The form reflects the
requirements of the Ethics in Government Act, subsequent amendments
pursuant to the STOCK Act and OGE's implementing regulations that must
be met by a person before access can be granted. These requirements
relate to information collected about the identity of the requester, as
well as any other person on whose behalf a record is sought, and
notification of prohibited uses of executive branch public disclosure
financial reports. See sections 105(b) and (c) and 402(b)(1) of the
Ethics in Government Act, 5 U.S.C. appendix Sec. Sec. 105(b) and (c)
and 402(b)(1), and 5 CFR 2634.603 (c) and (f) of OGE's executive
branchwide regulations. Executive branch departments and agencies are
encouraged to utilize the OGE Form 201 for individuals seeking access
to public financial disclosure reports and other covered documents. OGE
permits departments and agencies to use or develop their own forms as
long as the forms collect and provide all of the required information.
OGE is proposing several modifications to both the non-automated and
automated versions of the OGE Form 201. OGE proposes to modify the
title of the form and add a warning to requestors that intentional
falsification of the information required by the form may result in
prosecution under 18 U.S.C. Sec. 1001. OGE is proposing that this
[[Page 24750]]
renewal request to OMB also cover the fully automated version of the
OGE Form 201, available only through the OGE Web site at www.oge.gov.
Initially launched in March 2012, this automated version of the access
form enables a requestor to obtain immediately upon Web site submission
of the completed form, those financial disclosure reports of
individuals who have been nominated by the President to executive
branch positions requiring Senate confirmation. In addition, OGE
reviews the public financial disclosure report of individuals who have
declared their candidacy for the Office of the President of the United
States. Those certified reports may also be requested by submitting a
completed automated OGE Form 201.
Request for Comments: OGE is publishing this first round notice of
its intent to request paperwork clearance for a proposed modified OGE
Form 201 Ethics Act Access Form. Agency and public comment is invited
specifically on the need for and practical utility of this information
collection, the accuracy of OGE's burden estimate, the enhancement of
quality, utility and clarity of the information collected, and the
minimization of burden (including the use of information technology).
Comments received in response to this notice will be summarized for,
and may be included with, the OGE request for extension of OMB
paperwork approval. The comments will also become a matter of public
record.
Approved: April 22, 2013.
Walter M. Shaub, Jr.,
Director, U.S. Office of Government Ethics.
[FR Doc. 2013-09932 Filed 4-25-13; 8:45 am]
BILLING CODE 6345-03-P